MarketsandMarkets™ has released a new research report titled “US Sleep Apnea Devices Market by Product, Age, Gender, and End User – Forecast to 2031” (Report Code: MD 10284). According to the study, the US sleep apnea devices market is projected to grow from USD 3.11 billion in 2026 to USD 4.54 billion by 2031, registering a strong CAGR of 7.8% during the forecast period.
The market was valued at USD 2.90 billion in 2025, with growth driven by the rising prevalence of obstructive sleep apnea (OSA), increasing obesity rates, and growing awareness of the health risks associated with untreated sleep disorders. Expanded access to diagnostic and therapeutic technologies, along with a favorable reimbursement environment, continues to support market expansion across the US.
Home-Based Diagnosis and Patient-Centric Therapy Fuel Market Growth
The US healthcare system is increasingly shifting toward decentralized and home-based care, accelerating adoption of home sleep apnea testing (HSAT) devices and positive airway pressure (PAP) therapies. Improvements in device comfort, portability, connectivity, and remote monitoring capabilities are enabling faster diagnosis, earlier intervention, and improved long-term treatment adherence.
Growing investments in sleep health technology, coupled with advancements in digital health platforms, cloud-based data management, and telemedicine integration, are reshaping how sleep apnea is diagnosed and managed across hospitals, sleep clinics, physician offices, and home care settings.
Key Market Insights
-
By Product: The therapeutic devices segment—including CPAP, APAP, BPAP systems, masks, and oral appliances—is expected to register the highest CAGR of 11.3% during the forecast period.
-
By End User: Home care settings and self-testing are projected to grow at the fastest rate (8.5% CAGR), driven by convenience, cost-effectiveness, and remote patient monitoring.
-
By Age Group: Individuals aged 40–60 years accounted for 57.5% of the market share in 2025, reflecting higher diagnosis rates and increased treatment adoption.
-
By Gender: The male population held the largest market share in 2025 due to a higher prevalence of sleep apnea among men.
Technology Innovation and Reimbursement Support Market Momentum
Favorable reimbursement policies and increased financial support for sleep studies and treatment devices are key enablers of market growth in the US. Manufacturers are investing heavily in research and development to deliver next-generation PAP devices, ergonomic masks, and connected diagnostic tools that improve patient comfort and therapy compliance.
At the same time, rising demand for cost-effective home sleep apnea tests, along with growing adoption of telemedicine, mobile health (mHealth), and AI-driven solutions, is creating new opportunities across the sleep apnea care continuum.
Competitive Landscape Highlights
Major players in the US sleep apnea devices market include ResMed, Koninklijke Philips N.V., Fisher & Paykel Healthcare Limited, Inspire Medical Systems, Inc., and SomnoMed, supported by strong brand recognition, extensive product portfolios, and advanced digital health capabilities.
In addition, startups and SMEs such as Compumedics Limited, Löwenstein Medical SE & Co. KG, Drive DeVilbiss International, BMC, and BRAEBON Medical Corporation are strengthening their presence by addressing niche clinical needs and expanding access to specialized sleep apnea solutions.